Are Abaxis (ABAX) Shares a Sell Now? Sidoti Has Downgraded Stock

May 16, 2018 - By Migdalia James

Abaxis, Inc. (NASDAQ:ABAX) Logo

Investors sentiment decreased to 1.27 in Q4 2017. Its down 0.05, from 1.32 in 2017Q3. It is negative, as 12 investors sold Abaxis, Inc. shares while 40 reduced holdings. 25 funds opened positions while 41 raised stakes. 21.66 million shares or 0.81% less from 21.83 million shares in 2017Q3 were reported.

Wesbanco Bancorp owns 0.02% invested in Abaxis, Inc. (NASDAQ:ABAX) for 5,500 shares. Bessemer Group Inc reported 0% stake. Advisory Service Ntwk Limited Liability Company invested 0% of its portfolio in Abaxis, Inc. (NASDAQ:ABAX). Renaissance Techs Llc holds 0.01% or 162,971 shares in its portfolio. Riverhead Cap Mngmt Limited Liability Company stated it has 0% of its portfolio in Abaxis, Inc. (NASDAQ:ABAX). Arizona State Retirement reported 38,148 shares. Jpmorgan Chase & holds 0% of its portfolio in Abaxis, Inc. (NASDAQ:ABAX) for 93,999 shares. Neuberger Berman Ltd Liability Corp holds 0% or 20,254 shares in its portfolio. State Board Of Administration Of Florida Retirement System has 16,235 shares. C M Bidwell And Assocs Ltd, Hawaii-based fund reported 102 shares. Principal Fin Gp invested in 177,030 shares or 0.01% of the stock. State Of Alaska Department Of Revenue holds 4,527 shares. Northern Trust has 0% invested in Abaxis, Inc. (NASDAQ:ABAX) for 286,577 shares. Parallax Volatility Advisers Lp invested in 0% or 3,360 shares. 4,665 are owned by Piedmont Inv Advsr Lc.

Since January 30, 2018, it had 0 insider buys, and 10 selling transactions for $2.85 million activity. SINGH PRITHIPAL sold $149,255 worth of Abaxis, Inc. (NASDAQ:ABAX) on Tuesday, January 30. Shares for $98,266 were sold by ARON KENNETH. The insider Henkel Achim sold $304,953. CASEY MICHAEL D had sold 5,000 shares worth $355,327. 4,500 shares valued at $333,460 were sold by EVENHUIS HENK on Tuesday, January 30. Another trade for 1,650 shares valued at $122,652 was made by TOCKMAN CRAIG on Wednesday, January 31.

Abaxis (ABAX) Receives a Downgrade

Research professionals at Sidoti’s equity research division downgraded the rating for shares of Abaxis (ABAX) from a Buy to a Neutral on Wednesday, 16 May.

The stock increased 16.15% or $11.59 during the last trading session, reaching $83.34. About 4.19 million shares traded or 2804.89% up from the average. Abaxis, Inc. (ABAX) has risen 44.47% since May 17, 2017 and is uptrending. It has outperformed by 32.92% the S&P500.

Analysts await Abaxis, Inc. (NASDAQ:ABAX) to report earnings on July, 26. They expect $0.35 EPS, up 25.00 % or $0.07 from last year’s $0.28 per share. ABAX’s profit will be $7.95 million for 59.53 P/E if the $0.35 EPS becomes a reality. After $0.42 actual EPS reported by Abaxis, Inc. for the previous quarter, Wall Street now forecasts -16.67 % negative EPS growth.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. The company has market cap of $1.89 billion. It operates in two divisions, Medical Market and Veterinary Market. It has a 77.17 P/E ratio. The firm offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.

More notable recent Abaxis, Inc. (NASDAQ:ABAX) news were published by: Fool.com which released: “Why Under Armour, Boot Barn Holdings, and Abaxis Jumped Today” on May 16, 2018, also 247Wallst.com with their article: “Are Abaxis Shareholders Getting Enough in the Buyout?” published on May 16, 2018, Themiddlemarket.com published: “M&A daily wrap: NFL’s Carolina Panthers, Cam Newton, David Tepper, Appaloosa, Brynwood Partners” on May 16, 2018. More interesting news about Abaxis, Inc. (NASDAQ:ABAX) were released by: Benzinga.com and their article: “A Preview Of Abaxis Q4 Earnings” published on April 26, 2018 as well as Businesswire.com‘s news article titled: “INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Abaxis …” with publication date: May 16, 2018.

Abaxis, Inc. (NASDAQ:ABAX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.